NCT01924767View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

BI 10773 Placebo

po taken fasting with 240 mL water

DRUG

BI 10773

po taken fasting with 240 mL water

DRUG

BI 10773 Placebo

po taken fasting with 240 mL water

DRUG

BI 10773

po taken fasting with 240 mL water

DRUG

BI 10773 Placebo

po taken fasting with 240 mL water

DRUG

BI 10773 Placebo

po taken fasting with 240 mL water

DRUG

BI 10773

po taken fasting with 240 mL water

DRUG

BI 10773

po taken fasting with 240 mL water

Trial Locations (1)

Unknown

1245.2.1 Boehringer Ingelheim Investigational Site, Neuss

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01924767 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets | Biotech Hunter | Biotech Hunter